Microbiological monitoring in patients with advanced ovarian cancer before and after cytoreductive surgery – a preliminary report

1. Gersetein CG, Damhuis RAM, de Vries M, Reedijk A, Burger CW, Kooi GS. Causes of postoperative mortality after surgery for ovarian cancer. Eur J Cancer. 2009;45:2799-803.10.1016/j.ejca.2009.06.00419615887Search in Google Scholar

2. Chi DS, Eisenhauer EL, Zivanovic O, SonodaY, Abu-Rustum NR, Levine DA, et al. Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm. Gynecol Oncol. 2009;114:26-31.10.1016/j.ygyno.2009.03.01819395008Search in Google Scholar

3. Capone A, Valle M, Proietti F, Federici O, Garofalo A, Petrosillo N. Postoperative infections in cytoreductive surgery with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis. J Surg Oncol. 2007;96:507-13.10.1002/jso.2083717708508Open DOISearch in Google Scholar

4. Dazza M, Schwarz L, Coget J, Frebourg N, Wood G, Huet E, et al. Does intraoperative systematic bacterial sampling during complete cytoreductive surgery (CRS) with hyperthermic intraoperative peritoneal chemotherapy (HIPEC) inf luence postoperative treatment? A new predictive factor for postoperative abdominal infectious complications. World J Surg. 2016;40:3035-43.10.1007/s00268-016-3635-627412631Open DOISearch in Google Scholar

5. Matsuo K, Prather CP, Ahn EH, Eno ML, Tierney KE, Yessaian AA, et al. Significance of perioperative infection in survival of patients with ovarian cancer. Int J Gynecol Cancer. 2012;22:245-53.10.1097/IGC.0b013e31823bd6db22228425Open DOISearch in Google Scholar

6. Wołkowicz T, Januszkiewicz A, Szych J. Mikrobiom przewodu pokarmowego i jego dysbiozy jako istotny czynnik wpływający na kondycję zdrowotną organizmu człowieka. Med Dośw Mikrobiol. 2014;66:223-35.Search in Google Scholar

7. Jernberg C, Löfmark S, Edlund C, Jansson JK. Long-term impacts of antibiotic exposure on the human instestinal microbiota. Microbiology. 2010;156:3216-23.10.1099/mic.0.040618-020705661Search in Google Scholar

8. Esposito S, Capuano A, Noviello S, Mazzeo F, Ianniello F, Filippelli A. Modification of patients’ endogenous bacterial flora during hospitalization in a large teaching hospital in Naples. J Chemother. 2003;15:568-73.10.1179/joc.2003.15.6.56814998082Search in Google Scholar

9. Siegel JD, Rhinehart E, Jackson M, Chiarello L. The Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007;3:165-93. www.cdc.gov/infectioncontrol/guidelines/mdro, last update: February, 15, 2017.Search in Google Scholar

10. Valle M, Federici O, Carboni F, Toma L, Gallo MT, Prignano G, et al. Postoperative infections after cytoreductive surgery and HIPEC for peritoneal carcinomatosis: Proposal and results from a prospective protocol study of prevention, surveillance and treatment. EJSO. 2014;40:950-6.10.1016/j.ejso.2013.10.01524246609Search in Google Scholar

11. Harris AD, Nemoy L, Johnson JA, Martin-Carnahan A, Smith DL, Standiford H, et al. Co-carriage rates of vancomycin-resistant Enterococcus and extended-spectrum beta lactamase-producing bacteria among a cohort of intensive care unit patients: implications for an active surveillance program. Infect Control Hosp Epdemiol. 2004;25:105-8.10.1086/50235814994933Search in Google Scholar

12. Ostrowsky BE, Venkataraman L, D’Agata EM, Gold HS, DeGirolami PC, Samore MH. Vancomycin-resistant enterococci in intensive care units: high frequency of stool carriage during a non-outbreak period. Arch Intern Med. 1999;159:1467-72.10.1001/archinte.159.13.146710399898Search in Google Scholar

13. Warren DK, Nitin A, Hill C, Fraser VJ, Kollef MH. Occurrence of co-colonization or co-infection with vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol. 2004;25: 99-104.10.1086/502357Search in Google Scholar

14. Tran CW, McGree ME, Weaver AL, Martin JR, Lemens MA, Cliby WA, et al. Surgical site infection after primary surgery for epithelial ovarian cancer: predictors and impact on survival. Gynecol Oncol. 2015;136:278-84.10.1016/j.ygyno.2014.12.007Search in Google Scholar

15. Rafii A, Stoeckle E, Jean-Laurent M, Ferron G, Morice P, Houvenaeghel G, et al. Multi-center evaluation of post-operative morbidity and mortality after optimal cytroreductive surgery for advanced ovarian caner. Plose One. http://dx.doi.org/10.1371/journal.pone.0039415, 2012 (accessed 23.07.2012).10.1371/journal.pone.0039415,2012(accessed23.07.2012)Open DOISearch in Google Scholar

16. Sugarbaker PH. Peritonectomy procedures. Ann. Surg. 1995;221:29-42.Search in Google Scholar

17. Sugarbaker PH, Alderman R, Edwards G, Marquardt CE, Gushchin V, Esquivel J, et al. Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy. Ann Surg Oncol. 2006;13:635-44.10.1245/ASO.2006.03.079Open DOISearch in Google Scholar

18. Capitano B, Nicolau DP. Evolving epidemiology and costs of resistance to antimicrobial agents in long-term care facilities. J Am Med Dir Assoc. 2003;4(3 Suppl):S90-9.10.1016/S1525-8610(04)70338-2Search in Google Scholar

19. Alevizakos M, Gaitanidis A, Nasioudis D, Tori K, Flokas ME, Mylonakis E. Colonization with vancomycin-resistant enterococci and risk for bloodstream infection among patients with malignancy: a systemic review and meta-analysis. Open Forum Infect Dis.2017;4 (1):ofw246, Published online 2016 Dec. 7. https://doi.org/10.1093/ofid/ofw246.10.1093/ofid/ofw246541410228480243Open DOISearch in Google Scholar

20. Matar MJ, Tarrand J, Raad I, Rolston KV. Colonization and infection with vancomycin-resistant enterococcus among patients with cancer. Am J Infect Control. 2006;34:534-6.10.1016/j.ajic.2006.04.20517015161Open DOISearch in Google Scholar

21. Tacconelli E. New strategies to identify patients harbouring antibiotic-resistant bacteria at hospital admission. Clin Microbiol Infect. 2006;12:102-9.10.1111/j.1469-0691.2005.01326.x16441446Search in Google Scholar

22. Kuehnert MJ, Jernigan JA, Pullen AL, Rimland D, Jarvis WR. Association between mucositis severity and vancomycin-resistant entrococcal bloodstream infection in hospitalized cancer patients. Infect Control Hosp Epidemiol. 1999;20: 660-3.10.1086/50156110530642Search in Google Scholar

23. Zaas AK, Song X, Tucker P, Perl TM. Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci. Clin Infect Dis. 2002;35:1139-46.10.1086/34290412410472Search in Google Scholar

24. Almyroudis NG, Osawa R, Samonis G, Wetzler, Wang ES, McCarthy PL, et al. Discontinuation of systematic surveillance and contact precautions for vancomycin-resistant Enterococcus (VRE) and its impact on the incidence of VRE faecium bacteremia in patients with hematologic malignancies. Infect Control Hosp Epidemiol. 2016;37:398-403.10.1017/ice.2015.31026750087Search in Google Scholar

25. De Angelis G, Cataldo MA, De Waure C, Venturiello S, La Torre G, Cauda R, et al. Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systemic review and meta-analysis. J Antimicrob Chemother. 2014;69:1185-92.10.1093/jac/dkt52524458513Search in Google Scholar

26. Farr BM. Hospital wards spreading vancomycin-resistant enterococci to intensive care units: returning coals to Newcastle. Crit Care Med, 1998;26:1942-3.10.1097/00003246-199812000-000089875893Open DOISearch in Google Scholar

27. Weinstein JW, Roe M, Towns M, Sanders L, Thorpe JJ, Corey GR, et al. Resistant enterococci: a prospective study of prevalence, incidence, and factors associated with colonization in a university hospital. Infect Control Hosp Epidemiol. 1996;17:36-41.10.2307/30142363Search in Google Scholar

28. Kang ChI, Wi YM, Lee MY, Ko KS, Chung DR, Peck KR, et al. Epidemiology and risk factors of community onset infections caused by extended-spectrum ß-lactamase-producing Escherichia coli strains. J Clin Microbiol. 2012;50:312-7.10.1128/JCM.06002-11326415822162561Open DOISearch in Google Scholar

29. Rooney PJ, O’Leary MC, Loughrey AC, McCalmont M, Smyth B, Donaghy P. Nursing homes as a reservoir of extended-spectrum beta-lactamse (ESBL)-producing ciprofloxacin-resistant Escherichia coli. J Antimicrob Chemother.2009;64: 635-41.10.1093/jac/dkp22019549667Search in Google Scholar

30. Freeman JT, Gormack S, De Almeida MN, Roberts SA. Natural history of rectal colonization with extended–spectrum betalactamase producing Enterobacteriaceae: a retrospective review with up to 6 years of follow-up. Healthcare Infection. 2013;18:152-5. https://doi.org/10.1071/HI13013.10.1071/HI13013Open DOISearch in Google Scholar

31. Thouverez M, Talon D, Bertrand X. Control of Enterobacteriaceae producing extended-spectrum beta-lactamase in intensive care units: rectal screening may not be needed in non-epidemic situations. Infect Control Hosp Epidemiol. 2004;25:838-41.10.1086/50230515518025Search in Google Scholar

32. Zahar JR, Lortholary O, Martin C, Potel G, Plesiat P, Nordmann P. Addresssing the challenge of extended-spectrum beta-lactamases. Curr Opin Invest Drugs. 2009;10:172-80.Search in Google Scholar

33. Demiraslan H, Cevahir F, Berk E, Metan G, Cetin M, Alp E. Is surveillance for colonization of carbapenem-resistant gram-negative bacteria important in adult bone marrow transplantation units? Am J Infect Control. 2017;45:735-9.10.1016/j.ajic.2017.01.00628214159Open DOISearch in Google Scholar

34. Zimmerman FS., Assous MV, Bdolah-Abram T, Lachish T, Yinnon AM, Wiener-Well Y. Duration of carriage of carbapenem-resistant Enterobacteriaceae following hospital discharge. Am J Infect Control. 2013;41:190-4.10.1016/j.ajic.2012.09.02023449280Open DOISearch in Google Scholar

35. Zalecenia dotyczące postępowania w przypadku identyfikacji w zakładach opieki zdrowotnej szczepów bakterii Enterobacteriaceae wytwarzających karbapenemazy typu KPC. http://www.antybiotyki.edu.pl/pdf/KPC-20100305.Search in Google Scholar